Physician profile
Surendra Gupta
NPI 1629056338
$3,728.05
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $379 · 2021: $716 · 2022: $1,413 · 2023: $29.38 · 2024: $23.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $749.35 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $490.76 | 2020-2022 | |
| Amgen INC. | $435.72 | 2019-2023 | Tavneos, Parsabiv |
| Astrazeneca Pharmaceuticals Lp | $379.83 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $250.00 | 2022 | |
| Glaxosmithkline, LLC. | $246.95 | 2019-2022 | |
| Abbott Laboratories | $240.99 | 2021-2022 | |
| Novo Nordisk INC | $145.09 | 2019-2022 | |
| Pfizer INC. | $122.55 | 2019 | |
| Insmed, INC. | $121.34 | 2021 | |
| Janssen Pharmaceuticals, INC | $114.64 | 2022 | |
| Akebia Therapeutics INC | $113.06 | 2019 | |
| Vifor Pharma, INC. | $87.90 | 2022 | |
| Gilead Sciences, INC. | $83.63 | 2019 | |
| Lundbeck LLC | $83.33 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $39.57 | 2022 | |
| Sanofi Pasteur INC. | $23.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surendra Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.